Bleomycin for Injection Recalled Due to Mislabeling
Hikma Pharmaceuticals USA Inc. is recalling Bleomycin for Injection, USP due to mislabeling. The recall affects 1,152 vials distributed nationwide.
- Product
- BLEOMYCIN — BLEOMYCIN (BLEOMYCIN)
- Category
- Drug
- Distribution
- Distributed nationwide